Statements (60)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:Clinical_Trials
|
gptkbp:analysis |
statistical methods
|
gptkbp:application |
centralized database
|
gptkbp:biostatistics |
employed for data analysis
|
gptkbp:business_model |
gptkb:Advisory_Services
adhered to ethical standards |
gptkbp:clinical_trial |
4 years
observational phase NCT00446031 |
gptkbp:collaboration |
multidisciplinary teams
|
gptkbp:collaborations |
with pharmaceutical companies
with international partners |
gptkbp:collaborator |
various medical institutions
|
gptkbp:collection |
clinical data
surveys and medical records |
gptkbp:criteria |
diagnosed with pulmonary arterial hypertension
other forms of pulmonary hypertension |
gptkbp:data_type |
qualitative and quantitative
|
gptkbp:eligibility |
adults aged 18 and older
|
gptkbp:end_date |
gptkb:2010
|
gptkbp:events |
up to 5 years
regular assessments conducted. |
gptkbp:focus |
pulmonary arterial hypertension
|
gptkbp:funding |
government grants
|
gptkbp:future_plans |
suggested for ongoing research
|
gptkbp:has_limitations |
acknowledged in publications
|
https://www.w3.org/2000/01/rdf-schema#label |
REVEAL Study
|
gptkbp:impact |
improved understanding of PAH
|
gptkbp:is_studied_in |
cohort study
|
gptkbp:location |
gptkb:United_States
|
gptkbp:long_term_follow_up |
important for chronic conditions
|
gptkbp:notable_work |
contributed to medical literature
risk factors for pulmonary arterial hypertension |
gptkbp:objective |
evaluate clinical outcomes
identify treatment patterns |
gptkbp:outcomes_reported |
quality of life measures
|
gptkbp:participants |
mortality rates
patients with pulmonary arterial hypertension |
gptkbp:patient_education |
important aspect of the study
|
gptkbp:patient_involvement |
encouraged in the study
|
gptkbp:patient_population |
diverse population
|
gptkbp:provides_guidance_on |
influenced treatment protocols
|
gptkbp:provides_information_on |
available for research purposes
|
gptkbp:publication |
gptkb:Journal_of_the_American_College_of_Cardiology
|
gptkbp:registration |
part of a larger registry effort
|
gptkbp:research |
observational study
prospective study |
gptkbp:research_findings_publication |
peer-reviewed journals
|
gptkbp:research_output |
identified treatment efficacy
published in medical conferences |
gptkbp:safety |
prioritized throughout the study
|
gptkbp:sampled_in |
over 3,000 patients
|
gptkbp:scientific_goals |
improve patient outcomes
|
gptkbp:side_effect |
guides future research
monitored during the study |
gptkbp:sponsor |
gptkb:National_Institutes_of_Health
|
gptkbp:start_date |
gptkb:2006
|
gptkbp:topics |
other PAH research initiatives
|
gptkbp:bfsParent |
gptkb:Eylea
|
gptkbp:bfsLayer |
5
|